Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Phosphatidylglycerol-rich Gram-positive bacterial membrane is the essential lipid bilayer that serves as the primary permeability barrier for Gram-positive bacteria, distinguished by its high content of anionic phospholipids like phosphatidylglycerol (PG) and cardiolipin (Epand et al., 2007, Chem. Phys. Lipids). This structure is vital for maintaining the proton motive force, regulating osmotic pressure, and anchoring proteins involved in cell wall synthesis and nutrient transport (Strahl & Hamoen, 2010, Proc. Natl. Acad. Sci.). In clinical medicine, this membrane is a critical therapeutic target because its negative charge differs significantly from the zwitterionic, cholesterol-rich membranes of mammalian cells, allowing for selective toxicity (Malanovic & Lohner, 2016, Biochim. Biophys. Acta). Lipopeptide antibiotics, most notably daptomycin, target this membrane by binding to PG in a calcium-dependent manner, leading to membrane insertion, depolarization, and rapid cell death (Taylor & Palmer, 2016, Antioxid. Redox Signal.). Resistance often arises through the modification of PG into lysyl-phosphatidylglycerol by the enzyme MprF, which reduces the membrane's net negative charge and repels cationic antibiotics (Ernst & Peschel, 2011, Int. J. Med. Microbiol.). Understanding this target is crucial for treating serious infections caused by pathogens such as Staphylococcus aureus and Enterococcus species.
Calcium-dependent binding to phosphatidylglycerol, insertion into the lipid bilayer, formation of oligomeric complexes, and induction of rapid depolarization through ion leakage (primarily potassium), which leads to the inhibition of DNA, RNA, and protein synthesis (Humphries et al., 2013, Clin. Microbiol. Rev.; Taylor & Palmer, 2016, Antioxid. Redox Signal.).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylglycerol-rich Gram-positive bacterial membrane.